Neurontin and Zollinger-ellison syndrome - a phase IV clinical study of FDA data
No or few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or few reports are found.
What is Neurontin?
Neurontin has active ingredients of gabapentin. It is used in neuralgia. Currently, eHealthMe is studying from 106,010 Neurontin users.
What is Zollinger-ellison Syndrome?
Zollinger-ellison syndrome (increased production of the hormone gastrin from a small tumour of pancreas) is found to be associated with 128 drugs and 173 conditions by eHealthMe. Currently, we are studying 1,239 people who have Zollinger-ellison syndrome.
Do you take Neurontin and have Zollinger-ellison syndrome?Check whether Zollinger-ellison syndrome is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Neurontin side effects by duration, gender and age:
- Neurontin side effects (106,010 reports)
Zollinger-ellison syndrome treatments and more:
- Zollinger-ellison syndrome (1,239 reports)
All the drugs that are associated with Zollinger-ellison syndrome:
All the conditions that are associated with Zollinger-ellison syndrome:
How the study uses the data?
The study uses data from the FDA. It is based on gabapentin (the active ingredients of Neurontin) and Neurontin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Myrbetriq and Overdose - a second ago
- Aripiprazole and Thrombocytosis - 7 seconds ago
- Methocarbamol and Hernia - 8 seconds ago
- Dronabinol and Voriconazole drug interaction - 13 seconds ago
- Levothyroxine Sodium and Sinus Bradycardia - 18 seconds ago
- Rocephin and Quelicin drug interaction - 20 seconds ago
- Biktarvy and Vitamin D drug interaction - 22 seconds ago
- Soma and Stomatitis - 28 seconds ago
- Qualaquin and Ativan drug interaction - 32 seconds ago
- Clobazam and Miconazole Nitrate drug interaction - 37 seconds ago